Tech Company Financing Transactions
Jnana Therapeutics Funding Round
Jnana Therapeutics, operating out of Boston, received $50 million in investment from AbbVie Biotech Ventures, Avalon Ventures and Pfizer Venture Investments.
Transaction Overview
Company Name
Announced On
12/16/2017
Transaction Type
Venture Equity
Amount
$50,000,000
Round
Series A
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
6 Tide St.
Boston, MA 02210
USA
Boston, MA 02210
USA
Phone
Undisclosed
Website
Email Address
Overview
Jnana is building the first drug discovery platform dedicated to SLC transporters.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Joanne Kotz
Chief Scientific Officer
Joel Barrish
Vice President
Heather Blanchette
Vice President
Dean Brown
Vice President
Nick Pullen
VP - Bus. Development
Caroline Beer
VP - Finance
Brian Danieli
VP - Human Resources
Danielle Abdelahad
Browse more venture capital transactions:
Prev: 12/16/2017: Splice venture capital transaction
Next: 12/16/2017: Zero Motorcycles venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC investment data records reported here are derived from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs